Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside

2 hours ago 1

Maham Fatima

Wed, December 31, 2025 astatine 10:33 AM CST 2 min read

Guardant Health Inc. (NASDAQ:GH) is 1 of the hottest large-cap stocks of 2025. On December 22, Canaccord raised the firm’s terms people connected Guardant Health to $125 from $100 with a Buy standing connected the shares. The steadfast expects the beingness subject assemblage to support its existent upward inclination good into 2026. Guardant Health remains Canaccord’s apical recommendation, arsenic the steadfast believes that the banal offers the champion equilibrium of constricted downside and beardown maturation imaginable compared to its peers.

Mizuho besides raised the firm’s terms people connected Guardant Health Inc. (NASDAQ:GH) connected December 17 to $120 from $100 and maintained an Outperform standing connected the shares. As portion of its 2026 outlook, the steadfast updated its terms targets wrong the aesculapian devices and diagnostics sector. While valuations person returned to adjacent two-year highs pursuing Q3 2025 earnings, the steadfast suggests that determination is country for further aggregate expansion. This maturation is contingent connected healthcare emerging arsenic the preferred antiaircraft play portion marketplace superior continues to rotate done volatile AI and cryptocurrency mega-trades.

Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside

Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside

On December 15, Bank of America besides raised the firm’s terms people connected Guardant Health to $120 from $100 and kept a Buy standing connected the shares. This determination was made arsenic BofA is revising its terms targets crossed the Life Sciences and Diagnostic Tools assemblage arsenic portion of a 2026 outlook. The steadfast anticipates that existent manufacture headwinds volition subside, starring to a normalized marketplace situation by 2026. The steadfast believes that the superior catalyst for maturation volition beryllium a resurgence successful Biopharma spending, prompting BofA to prioritize companies with important vulnerability to R&D.

Guardant Health Inc. (NASDAQ:GH) is simply a precision oncology institution that provides humor and insubstantial tests and information sets successful the US and internationally.

While we admit the imaginable of GH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.


Read Entire Article